共 8 条
Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism
被引:92
作者:
Huang, Jiangeng
[1
]
Si, Luqin
[1
]
Jiang, Lingli
[1
]
Fan, Zhaoze
[1
]
Qiu, Jun
[1
]
Li, Gao
[1
]
机构:
[1] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Dept Pharmaceut, Wuhan 430030, Peoples R China
基金:
中国国家自然科学基金;
关键词:
P-glycoprotein;
pluronic F68 block copolymer;
CYP3A4;
Caco-2;
everted gut sac;
D O I:
10.1016/j.ijpharm.2007.12.028
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The aim of this work was to investigate the effects of pluronic F68 block copolymer on the P-gp-mediated transport of celiprolol (CEL) and CYP3A4-mediated formation of midazolam (MDZ) metabolite 1'-hydroxymidazolam. Over a range from 0.03 to 0.3%, pluronic F68 increased apical-to-basolateral permeability (AP-BL) and decreased basolateral-to-apical permeability (BL-AP) of the P-gp substrate CEL in Caco-2 cell monolayer with the efflux ratio values of 2.8 +/- 0.3 (0.03%), 2.6 +/- 0.3 (0.1%), 2.3 +/- 0.2 (0.3%), respectively. CEL transport across the intestinal mucosa in the everted gut sac model was also enhanced by the P-gp inhibitor verapamil and the pharmaceutical excipient pluronic F68. Furthermore, CYP3A4-catalyzed formation of 1'-hydroxymidazolam was inhibited by pluronic F68 with IC50 and K-i values of 0.11 and 0.16 mg/ml, respectively. The results indicate that pluronic F68 is a potent in vitro inhibitor of both P-gp and CYP3A4, suggesting a potential for pluronic F68 to modify the pharmacokinetics of orally administered drugs that are P-gp and/or CYP3A4 substrates in vivo. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:351 / 353
页数:3
相关论文